Nobel Prize in Medicine Honors Two Americans for Discovery of MicroRNA
The Nobel Prize in medicine was awarded Monday to Americans Victor Ambros and Gary Ruvkun for their discovery of microRNA, a fundamental principle governing how gene activity is regulated.
The Nobel Assembly said that their discovery is 'proving to be fundamentally important for how organisms develop and function.'
Ambrose performed the research that led to his prize at Harvard University. He is currently a professor of natural science at the University of Massachusetts Medical School. Rackham's research was performed at Massachusetts General Hospital and the Harvard Medical School, where he's a professor of genetics, said Thomas Perlmann, Secretary-General of the Nobel Committee.
Last year, the Nobel Prize in Physiology or Medicine went to Hungarian-American Katalin Karikó and American Drew Weissman for discoveries that enabled the creation of mRNA vaccines against COVID-19 that were critical in slowing the pandemic.
The prize carries a cash award of 11 million Swedish kronor ($1 million) from a bequest left by the prize's creator, Swedish inventor Alfred Nobel.
The announcement launched this year's Nobel prizes award season.
Nobel announcements continue with the physics prize on Tuesday, chemistry on Wednesday and literature on Thursday. The Nobel Peace Prize will be announced Friday and the Nobel Memorial Prize in Economic Sciences on Oct. 14.
The laureates are invited to receive their awards at ceremonies on Dec. 10, the anniversary of Nobel's death.
Hashtags
- ScienceHealth#Nobel,NobelPrize,Swedish,Americans,NobelCommittee,Hungarian-American,American,COVID-19,NobelPeacePrize,NobelMemorialPrize,VictorAmbros,GaryRuvkun,Ambrose,Rackham,ThomasPerlmann,KatalinKarikó,DrewWeissman,AlfredNobel,NobelAssembly,HarvardUniversity,UniversityofMassachusettsMedicalSchool,MassachusettsGeneralHospital,HarvardMedicalSchool
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Saudi Gazette
3 days ago
- Saudi Gazette
Measles holiday warning as cases rise in Europe
LONDON — Families traveling abroad this summer on holiday or to visit relatives are being warned about the rise in measles cases in Europe and other regions. Measles infections in Europe are at a 25-year high, while cases are also surging in countries such as Pakistan and Nigeria. Childhood vaccination rates in the UK that offer protection against measles, mumps and rubella (MMR) are still a long way below the recommended 95% uptake, with the lowest regional rates found in London at just over 73% vaccinated. The UK Health Security Agency is warning holidaymakers to make sure they are up to date with their vaccinations and stress that it is never too late to get vaccinated. The UKHSA's latest data on measles infections shows that an outbreak is continuing in England. Some 109 cases were confirmed in April and 86 so far in May. These cases have mostly been in unvaccinated children aged 10 years and under. London has reported almost half of all cases in the past four weeks. Dr Vanessa Saliba, consultant epidemiologist at the UK Health Security Agency, says the rise in cases in England reflects what is happening abroad - and that's a concern as the summer holiday season gets going. "It's essential that everyone, particularly parents of young children, check all family members are up to date with two MMR doses, especially if you are traveling this summer for holidays or visiting family," Dr Saliba said. "Measles cases are picking up again in England and outbreaks are happening in Europe and many countries with close links to the UK." Measles spreads very easily and can be a nasty disease, leading to complications like ear and chest infections and inflammation of the brain with some children tragically ending up in hospital and suffering life-long consequences, Dr Saliba added. "Nobody wants this for their child and it's not something you want to experience when away on holiday." The decline in vaccination rates in the UK - particularly since the Covid pandemic - has been mirrored in other countries, especially in Europe. The World Health Organization and UNICEF reported 127,350 measles cases in the European Region in 2024 - double the number of cases reported during the previous year and the highest number since 1997. This year has seen outbreaks in several other European countries popular with UK holidaymakers, including France, Italy, Spain and Germany. The WHO has also reported that Romania, Pakistan, India, Thailand, Indonesia and Nigeria currently have among the largest number of measles cases worldwide. There has been a big push to improve MMR vaccination rates across the UK, but Dr Amanda Doyle, national director for primary care and community services at NHS England, says there is still a lot of work to do. "Too many babies and young children are still not protected against the diseases, which are contagious infections that spread very easily and can cause serious health problems. "MMR jabs are provided free as part of the NHS routine immunization program – and I would encourage all parents to act on invites or check vaccination records if they think they may have missed their child's vaccination." Health experts say that anyone, whatever their age, who has not had two doses of the MMR vaccine can contact their GP surgery to book an appointment and that it is never too late to catch up. Common symptoms include: high fever sore, red and watery eyes runny nose coughing sneezing Small white spots may appear inside the mouth. A blotchy red or brown rash usually appears after a few days, typically on the face and behind the ears, before spreading to the rest of the body. It can be harder to see on brown and black skin. Measles normally clears up within seven to 10 days. However, it can lead to pneumonia, meningitis, blindness and seizures. Babies and young children, pregnant women and those with a weakened immune system are at increased risk. Getting it while pregnant can lead to stillbirth, miscarriage or babies being born small. Measles can be fatal, but this is rare. — BBC
Leaders
6 days ago
- Leaders
UN Chief Demands Immediate Release of Aid Workers Held by Houthis
United Nations Secretary-General Antonio Guterres on Tuesday demanded Iran-backed Yemen's Houthis release dozens of aid workers, including UN staff members. This demand comes one year after the rebels arrested these individuals, highlighting the ongoing humanitarian crisis in Yemen. The Iran-backed Houthis control much of war-torn Yemen and detained 13 UN personnel along with over 50 aid group employees last June. Guterres emphasized the need for their immediate and unconditional release in a statement issued by his special envoy for Yemen, Hans Grundberg. Protection for Humanitarian Workers 'The UN and its humanitarian partners should never face targeting, arrest, or detention while serving the people,' Guterres stated. His remarks underscore the critical role humanitarian workers play in alleviating suffering in conflict zones. A decade of civil war has plunged Yemen into one of the world's worst humanitarian crises, with more than half of Yemen's population relies on aid for survival, making the situation increasingly dire. Impact of the Arrests The arrests prompted the United Nations to limit its deployments and suspend activities in some regions of Yemen. The Houthis claimed an 'American-Israeli spy cell' operated under the guise of aid groups, an accusation firmly rejected by the UN. Guterres also expressed sorrow over the 'deplorable tragedy' of a World Food Programme staff member's death in detention this past February. The Houthis have kidnapped, arbitrarily detained, and tortured hundreds of civilians, including aid workers, during their conflict against a Saudi-led coalition. The UN continues to advocate for the safety and release of detained aid workers in Yemen. The international community must support these efforts to ensure humanitarian access and protect those who serve vulnerable populations. Short link : Post Views: 5
Al Arabiya
7 days ago
- Al Arabiya
Harvard seeks end to US funding cuts, says national security, says research at risk
Harvard University asked a federal judge on Monday to issue a summary judgment ruling to unfreeze $2.5 billion in funding blocked by President Donald Trump's administration, which Harvard said was illegal. Harvard's filing in the US District Court in Boston said that it had received 957 orders since April 14 to freeze funding for research pertaining to national security threats, cancer and infectious diseases and more since the country's oldest and wealthiest school rejected a White House list of demands. Trump has said he is trying to force change at Harvard - and other top-level universities across the US-because in his view they have been captured by leftist 'woke' thought and become bastions of antisemitism. The Trump administration did not immediately respond to a request for comment. US District Judge Allison Burroughs has set arguments for July 21 on Harvard's motion for summary judgment, which is a request for a judge to decide a dispute without a trial to determine material facts. Harvard sued the Trump administration in April, alleging the funding freeze violated the school's right to free speech and was arbitrary and capricious. In Monday's court filing, Harvard detailed the terminated grants, including $88 million for research into pediatric HIV, $12 million for increasing Defense Department awareness of emerging biological threats and $8 million to better understand dark energy. The school said ending the funding would destroy ongoing research into cancer treatments, infectious disease and Parkinson's. The Trump administration has opened numerous investigations into Harvard. Some are looking at threats against Jewish students and faculty after pro-Palestinian protests broke out following the Oct. 7, 2023 Hamas attack on Israel and subsequent Israeli military actions in Gaza. Other investigations are probing whether Harvard discriminates based on sex and gender, along with the school's ties to foreign governments and international students. The Trump administration revoked , which a judge temporarily blocked after Harvard sued in a separate case. Harvard and other universities say Trump's attacks are threats to freedom of speech and freedom of academics, as well as threats to the schools' very existence.
